PBAC moves to ease ADHD treatment access
Medical Republic
The PBAC has recommended changes to expand access to non-stimulant ADHD medications, allowing more doctors to prescribe them and making them available to patients who do not respond well to stimulants. These changes aim to align PBS restrictions with current clinical guidelines and improve treatment access without shifting these medications to first-line use. The recommendations are part of an ongoing review and will require government approval before implementation.
All articles from 20 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.